Abstract:Background: Excessive endogenous glucose production is a major contributing factor for fasting hyperglycemia in diabetes. Results: FoxO6 deficiency attenuates hepatic gluconeogenesis and protects against fat-induced glucose disorder in mice. Conclusion: FoxO6 plays a significant role in regulating gluconeogenesis in the liver. Significance: FoxO6 is a potential therapeutic target for improving glucose metabolism in diabetes. Excessive endogenous glucose production contributes to fasting hyperglycemia in diabetes. FoxO6 is a distinct member of the FoxO subfamily. To elucidate the role of FoxO6 in hepatic gluconeogenesis and assess its contribution to the pathogenesis of fasting hyperglycemia in diabetes, we generated FoxO6 knock-out (FoxO6-KO) mice followed by determining the effect of FoxO6 loss-of-function on hepatic gluconeogenesis under physiological and pathological conditions. FoxO6 depletion attenuated hepatic gluconeogenesis and lowered fasting glycemia in FoxO6-KO mice. FoxO6-deficient primary hepatocytes were associated with reduced capacities to produce glucose in response to glucagon. When fed a high fat diet, FoxO6-KO mice exhibited significantly enhanced glucose tolerance and reduced blood glucose levels accompanied by improved insulin sensitivity. These effects correlated with attenuated hepatic gluconeogenesis in FoxO6-KO mice. In contrast, wild-type littermates developed fat-induced glucose intolerance with a concomitant induction of fasting hyperinsulinemia and hyperglycemia. Furthermore, FoxO6-KO mice displayed significantly diminished macrophage infiltration into liver and adipose tissues, correlating with the reduction of macrophage expression of C-C chemokine receptor 2 (CCR2), a factor that is critical for regulating macrophage recruitment in peripheral tissues. Our data indicate that FoxO6 depletion protected against diet-induced glucose intolerance and insulin resistance by attenuating hepatic gluconeogenesis and curbing macrophage infiltration in liver and adipose tissues in mice.

Forkhead Box P1 (FOXP1) Transcription Factor Regulates Hepatic Glucose Homeostasis

SCP4 Promotes Gluconeogenesis through FoxO1/3a Dephosphorylation.

Regulation Of Glucose Homeostasis And Lipid Metabolism By Ppp1r3g-Mediated Hepatic Glycogenesis

Nuclear Transcription Factor Foxo1 and Glucose,lipid Metabolism

The hepatic FOXQ1 transcription factor regulates glucose metabolism in mice

Aberrant Forkhead Box O1 Function is Associated with Impaired Hepatic Metabolism

Forkhead Box O6 (foxo6) Depletion Attenuates Hepatic Gluconeogenesis and Protects Against Fat-induced Glucose Disorder in Mice.

FoxO6 Integrates Insulin Signaling with Gluconeogenesis in the Liver.

The transcription factor Foxp1 regulates aerobic glycolysis in adipocytes and myocytes

KLF10 transcription factor regulates hepatic glucose metabolism in mice

FOXO1 competes with carbohydrate response element-binding protein (ChREBP) and inhibits thioredoxin-interacting protein (TXNIP) transcription in pancreatic beta cells

A Mutant Allele Encoding DNA Binding–Deficient FoxO1 Differentially Regulates Hepatic Glucose and Lipid Metabolism

FoxO1 Links Hepatic Insulin Action to Endoplasmic Reticulum Stress

Translocation of forkhead box O1 to the nuclear periphery induces histone modifications that regulate transcriptional repression of PCK1 in HepG2 cells

An insulin-independent mechanism for transcriptional regulation of Foxo1 in type 2 diabetic mice

Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1

Forkhead Box O1/Pancreatic and Duodenal Homeobox 1 Intracellular Translocation is Regulated by C-Jun N-Terminal Kinase and Involved in Prostaglandin E-2-Induced Pancreatic Beta-Cell Dysfunction

FoxO1 Plays an Important Role in Regulating Β-Cell Compensation for Insulin Resistance in Male Mice.

FOXP1 Inhibits High Glucose-Induced ECM Accumulation and Oxidative Stress in Mesangial Cells.

Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice

Regulation of FoxOs Transcription Factors on Body Metabolism